Last 1,434 GBp
Change Today -7.00 / -0.49%
Volume 7.2M
As of 11:35 AM 09/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Marc Dunoyer

Chief Financial Officer and Executive Director, AstraZeneca PLC
AgeTotal Calculated CompensationThis person is connected to 20 board members in 2 different organizations across 4 different industries.

See Board Relationships
62296,000 GBP
As of Fiscal Year 2013

Background*

Mr. Marc Dunoyer has been the Chief Financial Officer of AstraZeneca PLC since November 1, 2013. Mr. Dunoyer served as Executive Vice President of Global Portfolio & Product Strategy at AstraZeneca PLC from June 2013 to October 2013. He served as the Global Head of Rare Diseases Unit of JCR Pharmaceuticals Co., Ltd. He served as Head of Rare Diseases Unit at GlaxoSmithKline since February 2010. He served as President of Asia Pacific/Japan at GlaxoSmithKline plc until ...

Read Full Background

Corporate Headquarters*

980 Great West Road
Brentford, Middlesex TW8 9GS

United Kingdom

Phone: 44 20 8047 5000
Fax: --

Board Members Memberships*

Chairman
2010-N/A
Former Global Head of Rare Diseases Unit and Executive Director
2013-Present
Chief Financial Officer and Executive Director

Education*

MBA
Ecole des Hautes Etudes Commerciales de Montreal
LLB
Université de la Sorbonne - Université de Paris

Other Affiliations*

Annual Compensation*

Salary113,000 GBP
Bonus146,000 GBP
Total Annual Compensation259,000 GBP

Stock Options*

All Other Compensation37,000 GBP

Total Compensation*

Total Annual Cash Compensation296,000 GBP
Total Short Term Compensation259,000 GBP
Other Long Term Compensation37,000 GBP
Total Calculated Compensation296,000 GBP
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GSK:LN 1,434.00 GBp -7.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
€2.9M
Robert J. Hugin MBAChairman, Chief Executive Officer and Chairman of Executive Committee
Celgene Corporation
$1.3M
Andrew Philip Witty Chief Executive Officer, Executive Director, Member of Corporate Administration & Transactions Committee and Member of Finance Committee
GlaxoSmithKline plc
2.9M GBP
Lars Rebien Sørensen Chief Executive Officer
Novo Nordisk A/S
kr15.2M
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.5M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GLAXOSMITHKLINE PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.